The Functional Assessment of Migraine Scale development datasets.

The Functional Assessment of Migraine Scale (FAMS) is a newly developed questionnaire that allows patients to indicate their response to migraine treatment [1]. The datasets provided in this article were collected on patients with migraine using survey methodology in two rounds of data collection. In the first dataset (n = 100), patients were shown 210 proposed questions for the FAMS and rated their usefulness and/or relevance for assessing their treatment response [2]. Using factor analyses, the best items were selected for the second data collection (n = 200). Patients completed the final proposed 72 items along with two other popular measures of migraine assessment [3]. Both datasets include demographic and migraine related information (gender, race, medication, number of headache and migraine days). These data provide a wealth of information about the number and types of medications a patient with migraine may take, coupled with information about their perceived response to treatment with those medications. Because the FAMS was developed to assess a wide range of concerns voiced by patients, this data offers new insights into a large health population beyond the normal scope of research studies.

Development of the functional assessment of migraine scale using a patient guided approach.

PURPOSE: A better understanding of the multi-dimensional burden and impact of migraine has grown over recent years, yet the tools used to measure these concepts have not been updated to reflect such findings. Additionally, due to the increase in the number of both prophylactic and acute therapeutic options for migraine, a comprehensive assessment of treatment response is necessary. The goal of this project was to develop a patient guided outcome measure which evaluates patient identified efficacy factors when appraising migraine treatment response. METHODS: A group of patients with migraine (N = 10) were given an in-person semi-structured interview collecting information regarding a patient's perspective on meaningful response to headache and migraine treatment. Using the patient information collected during these interviews, a set of questions aimed at evaluating meaningful response were developed. Two additional groups (N = 100, 200) of patients with migraine then provided feedback on the drafted questions in an online setting. RESULTS: Interviews indicated thematic areas of interest to patients with migraine are not commonly assessed on popular measures. Over two hundred items were developed to assess thematic areas indicated by patients. Factor analysis used on the focus groups' results led to the development of an 18-item scale (Functional Assessment of Migraine Scale-Research: FAMS-R) that assesses the impact of migraine on a patient and shows the potential to measure treatment response. CONCLUSION: The FAMS portrays promising results at measuring a multi-faceted migraine treatment response and disease impact.

An Exploratory Analysis of Violent Offending and the Acquired Capability for Suicide in Male Prisoners.

Recently, the Interpersonal Theory of Suicide has offered some understanding as to why inmates are at a disproportionately high risk to die by suicide. The present study was designed to investigate how one aspect of the theory, the acquired capability for suicide, may differ between prison inmates with violent offenses versus those without. Data from 343 male prisoners within the Mississippi Department of Corrections were used to examine potential differences between these two groups on scales of the Acquired Capability for Suicide Scale. Contrary to the hypothesis that violent offenders would evidence higher levels of acquired capability, only the Spectator Enjoyment of Violence subscale was significantly different between the two groups, with nonviolent offenders producing higher scores. Potential explanations for these findings and implications for correctional mental health care providers are discussed.